Home Medicine A levothyroxine dose recommendation for the treatment of children and adolescents with autoimmune thyroiditis induced hypothyroidism
Article
Licensed
Unlicensed Requires Authentication

A levothyroxine dose recommendation for the treatment of children and adolescents with autoimmune thyroiditis induced hypothyroidism

  • Victoria Ellerbroek EMAIL logo , Katharina Warncke , Julia Köhle and Walter Bonfig EMAIL logo
Published/Copyright: June 8, 2013

Abstract

Objective: To determine a levothyroxine (T4) dose recommendation for the treatment of autoimmune thyroiditis (AIT)-induced hypothyroidism.

Methods: T4 doses in 75 children and adolescents with newly diagnosed AIT were prospectively collected and compared to T4 doses of patients with congenital hypothyroidism (CH, n=22).

Results: Sixty-four patients with AIT and 22 patients with CH were included in the analysis. The thyroid-stimulating hormone declined significantly from 25.8±50.1 to 2.1±1.5 μIU/mL (AIT group; p<0.01) and from 338.7±380.7 to 1.9±1.6 μIU/mL (CH group; p<0.01). The required T4 dose for patients with AIT was 1.5±0.5 μg/kg per day (≥6 to <10 years: 2.0±0.4 μg T4/kg per day; ≥10 to <12 years: 1.6±0.4 μg T4/kg per day; ≥12 to <14 years: 1.5±0.6 μg T4/kg per day; ≥14 years: 1.4±0.6 μg T4/kg per day). It deviated significantly from the CH patients’ mean T4 dose of 2.8±0.7 μg T4/kg per day, p<0.01. CH patients with athyreosis required an average dose of 3.1±0.5 μg T4/kg per day; patients with ectopia, 2.6±0.7 μg T4/kg per day; and patients with dyshormonogenesis, 2.5±0.6 μg T4/kg per day.

Conclusion: Juvenile patients with AIT require significantly lower T4 doses than patients with CH.


Corresponding authors: Victoria Ellerbroek and Walter Bonfig, Department of Pediatrics, Children’s Hospital, Technical University of Munich, Parzivalstr. 16, 80804 München, Germany, Phone: +49 89 3068 2589, Fax: +49 89 3068 3849, E-mail: ;

References

1. Zois C, Stavrou I, Kalogera C, Svarna E, Dimoliatis I, et al. High prevalence of autoimmune thyroiditis in schoolchildren after elimination of iodine deficiency in northwestern Greece. Thyroid 2003;13:485–89.10.1089/105072503322021151Search in Google Scholar

2. Rallison ML, Dobyns BM, Meikle AW, Bishop M, Lyon JL, et al. Natural history of thyroid abnormalities: prevalence, incidence, and regression of thyroid diseases in adolescents and young adults. Am J Med Genet 1991;91:363–70.10.1016/0002-9343(91)90153-OSearch in Google Scholar

3. Gaudino R, Garel C, Czernichow P, Léger J. Proportion of various types of thyroid disorders among newborns with congenital hypothyroidism and normally located gland: a regional cohort study. Clin Endocrinol (Oxf) 2005;62:444–8.10.1111/j.1365-2265.2005.02239.xSearch in Google Scholar

4. Skordis N, Toumba M, Savva SC, Erakleous E, Topouzi M, et al. High prevalence of congenital hypothyroidism in the Greek Cypriot population: results of the neonatal screening program 1990–2000. J Pediatr Endocrinol Metab 2005;18:463–71.10.1515/JPEM.2005.18.5.453Search in Google Scholar

5. Rivkees SA, Bode HH, Crawford JD. Long-term growth in juvenile acquired hypothyroidism: the failure to achieve normal adult stature. N Engl J Med 1988;318:599–602.10.1056/NEJM198803103181003Search in Google Scholar

6. Rovet JF. Congenital hypothyroidism: long-term outcome. Thyroid 1999;9:741–8.10.1089/thy.1999.9.741Search in Google Scholar

7. Arbeitsgemeinschaft Pädiatrische Endokrinologie (APE) als Sektion der Deutschen Gesellschaft für Kinderheilkunde und Jugendmedizin (DGKJ) sowie der Deutschen Gesellschaft für Endokrinologie (DGE) Sektion Pädiatrische Endokrinologie und Diabetologie (2012). Leitlinie Autoimmunthyreoiditis. Available at: http://www.awmf.org/leitlinien/detail/ll/027-040.html.Search in Google Scholar

8. Brown RS. The thyroid. In: Brook C, Clayton P, Brown RS, editors. Brook’s clinical pediatric endocrinology, 6th ed. New York: Wiley-Blackwell, 2009:250–81.Search in Google Scholar

9. Latrofa F, Pinchera A. Autoimmune hypothyroidism. In: Weetman AP, editor. Autoimmune diseases in endocrinology, 12th ed. New Jersey: Humana Press, 2008:137–76.Search in Google Scholar

10. Deutsche Gesellschaft für Endokrinologie, Deutsche Gesellschaft für Kinder- und Jugendmedizin e.V., Arbeitsgemeinschaft Pädiatrische Endokrinologie. Diagnostik, Therapie und Verlaufskontrolle der Primären angeborenen Hypothyreose. Available at:http://www.awmf.org/leitlinien/detail/ll/027-017.html.Search in Google Scholar

11. Rose SR, Brown RS, Foley T, Kaplowitz PB, Kaye CI, et al. Update of newborn screening and therapy for congenital hypothyroidism. American Academy of Pediatrics and American Thyroid Association. Pediatrics 2006;117:2290–303.Search in Google Scholar

12. Taketomo CK, Hodding JH, Kraus DM, editors. Lexi-Comp’s pediatric dosage handbook with international trade names index: including neonatal dosing, drug administration, and extemporaneous preparations. American Pharmacist Association (APhA). Hudson, Ohio: Lexi-Comp, 2011.Search in Google Scholar

13. Fisher DA, Grueters A. Thyroid disorders in childhood and adolescence. In: Sperling M, editor. Pediatric endocrinology, 3rd ed. Philadelphia: Saunders/Elsevier, 2008:227–53.Search in Google Scholar

14. Van Vliet G. Hypothyroidism in infants, children and adolescents: Acquired hypothyroidism. In: Braverman LE, Utiger RD, editors. The thyroid: A fundamental and clinical text, 9th ed. Philadelphia: Lippincott Williams and Wilkins, 2005:1041–47.Search in Google Scholar

15. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3–126.10.1089/105072503321086962Search in Google Scholar

16. Roche Diagnostics GmbH. Reference intervals for children and adults: Elecsys thyroid tests. Mannheim, Germany, 2009.Search in Google Scholar

17. Mosteller RD. Simplified calculation of body surface area. N Engl J Med 1987;317:1098.10.1056/NEJM198710223171717Search in Google Scholar

18. De Fries L, Bulvik S, Phillip M. Chronic autoimmune thyroiditis in children and adolescents: at presentation and during long-term follow-up. Am J Dis Child 2008;94:33–7.10.1136/adc.2007.134841Search in Google Scholar

19. Abbassi V, Aldige C. Evaluation of sodium l-thyroxine (T4) requirement in replacement therapy of hypothyroidism. J Pediatr 1977;90:298.10.1016/S0022-3476(77)80656-2Search in Google Scholar

20. Rezvani IR, DiGeorge AM. Reassessment of the daily dose of oral thyroxine for replacement therapy in hypothyroid children. J Pediatr 1977;90:291.10.1016/S0022-3476(77)80655-0Search in Google Scholar

21. Gordon MB, Gordon MS. Variations in adequate levothyroxine replacement therapy in patients with different causes of hypothyroidism. Endocr Pract 1999;5:233–8.10.4158/EP.5.5.233Search in Google Scholar PubMed

22. Radetti G, Gottardi E, Bona G, Corrias A, Salardi S, et al. The natural history of euthyroid Hashimoto’s thyroiditis in children. J Pediatr 2006;149:827–32.10.1016/j.jpeds.2006.08.045Search in Google Scholar PubMed

23. Fava A, Oliverio R, Giuliano S, Parlato G, Michniewicz A, et al. Clinical evolution of autoimmune thyroiditis in children and adolescents. Thyroid 2009;19:361–7.10.1089/thy.2008.0239Search in Google Scholar PubMed

24. Özen S, Berk Ö, Simsek DG, Darcan S. Clinical course of Hashimoto’s thyroiditis and effects of levothyroxine therapy on the clinical course of the disease in children and adolescents. J Clin Res Pediatr Endocrinol 2011;3:192–7.10.4274/jcrpe.425Search in Google Scholar PubMed PubMed Central

Received: 2013-1-26
Accepted: 2013-5-14
Published Online: 2013-06-08
Published in Print: 2013-11-01

©2013 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Review article
  4. Application of imaging modalities for evaluating neuroblastoma
  5. Images in pediatric endocrinology
  6. Lingual thyroid
  7. Original articles
  8. A levothyroxine dose recommendation for the treatment of children and adolescents with autoimmune thyroiditis induced hypothyroidism
  9. Fasting glucagon-like peptide-1 in patients with overt hyperthyroidism and euthyroid congenital hypothyroidism
  10. Perinatal complications and higher risks of offspring thyroid dysfunction in early childhood of Graves’ disease mothers with euthyroidism
  11. Clinical characteristics and management of cranial diabetes insipidus in infants
  12. Desmopressin administration in children with central diabetes insipidus: a retrospective review
  13. An electronic surveillance system for monitoring the hospital presentation of nutritional vitamin D deficiency in children in Scotland
  14. Frequency and severity of ketoacidosis at onset of autoimmune type 1 diabetes over the past decade in children referred to a tertiary paediatric care centre: potential impact of a national programme highlighted
  15. Vitamin D status is associated with early markers of cardiovascular disease in prepubertal children
  16. Evaluation of bone mineral density in children with type 1 diabetes mellitus
  17. Observational study of diabetes management in type 1 diabetic school-age children during holiday versus school days
  18. Relationship of body mass index and GAD65 antibody status on β-cell secretion at diabetes onset in African-American children
  19. Serum dipeptidyl peptidase 4 activity in children with type 1 diabetes mellitus
  20. Concomitant autoantibodies in newly diagnosed diabetic children with transient celiac serology or proven celiac disease
  21. Assessment of user-friendliness of the Norditropin FlexPro for pediatric patients treated with recombinant human growth hormone: results of an open-label user survey
  22. Cognitive impairment and gray/white matter volume abnormalities in pediatric patients with Turner syndrome presenting with various karyotypes
  23. Prevalence of metabolic syndrome among urban Indian adolescents and its relation with insulin resistance (HOMA-IR)
  24. Prevalence of metabolic syndrome in obese Chilean children and association with gene variants of the leptin-melanocortin system
  25. Evaluation of serum neopterin levels and its relationship with adipokines in pediatric obesity-related nonalcoholic fatty liver disease and healthy adolescents
  26. Could GSD type I expand the spectrum of disorders with elevated plasma chitotriosidase activity?
  27. Patient reports
  28. Treatment of hyperinsulinemic hypoglycemia because of diffuse nesidioblastosis with nifedipine after surgical therapies in a newborn
  29. Successful subcutaneous glucagon use for persistent hypoglycaemia in congenital hyperinsulinism
  30. A novel atypical presentation of insulin autoimmune syndrome (Hirata’s disease) in a child
  31. Diagnosis of septo-optic dysplasia in a neonate with hypernatremia, hypoglycemia, and persistent hypothermia
  32. Speech and language delay in two children: an unusual presentation of hyperthyroidism
  33. Lissencephaly presenting with congenital hypothyroidism
  34. PHEX gene mutation in a Chinese family with six cases of X-linked hypophosphatemic rickets
  35. Primary hyperparathyroidism as an extremely rare cause of secondary myelofibrosis in childhood
  36. A family with Camurati-Engelman disease: the role of the missense p.R218C mutation in TGFbeta1 in bones and endocrine glands
  37. A case of SCNN1A splicing mutation presenting as mild systemic pseudohypoaldosteronism type 1
  38. Central precocious puberty in a girl with Prader-Willi syndrome
  39. Type 1 diabetes mellitus in a patient with homozygous sickle cell anemia
  40. Short communication
  41. No impact of obesity susceptibility loci on weight regain after a lifestyle intervention in overweight children
  42. Letter to the Editor
  43. Reliability and validity of homeostasis model assessment for insulin resistance and β-cell dysfunction in critically ill children with hyperglycemia
Downloaded on 12.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0038/html
Scroll to top button